Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir Technologies is highly profitable but currently overvalued, with EV/EBITDA ratio of 676.74 and P/E ratio of 513.78.

Shares of Palantir Technologies (NASDAQ:PLTR) sold-off after reporting Q1 earnings on May 5, but since then, the stock has ...

Palantir Technologies Inc (NASDAQ:PLTR) hits $300B market cap, up from $20B in 2 years. CEO praises Saudi engineers, ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

U.S. stock futures edge higher, Nvidia stock continues to climb after surging yesterday on an AI deal with a Saudi firm, and ...

Nvidia CEO Jensen Huang said on Tuesday during an investment forum in Saudi Arabia — which was attended by President Donald Trump and other Big Tech CEOs — that the chipmaker will ship its ...

The Dow opened lower after the Consumer Price Index report showed annual inflation slowed to 2.3%, marking the lowest inflation rate since early 2021. Follow along for live updates on the Dow, S&P 500 ...

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that ...

Live Updates Live Coverage Has Ended Palantir Still Gaining Substantial Traction 1:57 pm At a new all-time high, Palantir ...

Although Palantir Technologies Inc. (PLTR) stock has a “nosebleed” valuation, it does look attractive, based on the ...

The Wall Street bank reiterated a Buy rating for Palantir and raised its forecast from $125 per share to $150, implying ...